Cargando…
IgM‐enriched immunoglobulin as adjuvant therapy for heart transplant after infection of left ventricular assist devices
Patients undergoing heart transplantation (HTx) with active infection of left ventricular assist devices (LVAD) are at high risk for postoperative infections. Between 2021 and 2022, five (P1–P5) of a total of n = 44 patients underwent HTx in our department while suffering from LVAD infection. Postop...
Autores principales: | Immohr, Moritz Benjamin, Böttger, Charlotte, Aubin, Hug, Westenfeld, Ralf, Oehler, Daniel, Bruno, Raphael Romano, Dalyanoglu, Hannan, Tudorache, Igor, Akhyari, Payam, Lichtenberg, Artur, Boeken, Udo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715847/ https://www.ncbi.nlm.nih.gov/pubmed/35854478 http://dx.doi.org/10.1002/ehf2.14074 |
Ejemplares similares
-
Cytomegalovirus mismatch after heart transplantation: Impact of antiviral prophylaxis and intravenous hyperimmune globulin
por: Immohr, Moritz B., et al.
Publicado: (2021) -
Treatment of donor‐specific antibody‐mediated rejection after heart transplantation by IgM‐enriched human immunoglobulin
por: Immohr, Moritz Benjamin, et al.
Publicado: (2021) -
Impact of pretransplant left ventricular assist device support duration on outcome after heart transplantation
por: Immohr, Moritz Benjamin, et al.
Publicado: (2021) -
Preoperative atrial fibrillation predicts worse outcomes after LVAD implantation
por: Immohr, Moritz Benjamin, et al.
Publicado: (2022) -
The quality of afterlife: surviving extracorporeal life support after therapy‐refractory circulatory failure—a comprehensive follow‐up analysis
por: Immohr, Moritz Benjamin, et al.
Publicado: (2021)